Arca
Skip to content

Actinic keratosis

Drug research and approvals for actinic keratosis: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.

As of Nov 16, 2026, 36 studies of actinic keratosis are recruiting on ClinicalTrials.gov, Health Canada has authorized 6 drug trials for it since 2013, and the EU has 3 authorised medicines for it.

  • Recruiting worldwide: 36
  • Trials authorized in Canada: 6
  • FDA orphan approvals: 0
  • EU medicines: 3

Recruiting Now

Newest start dates first, of 36 recruiting on ClinicalTrials.gov ↗

Trials Authorized in Canada

Newest first; search them all in Canada trials
Dec 15, 2015Efficacy and safety of leo 43204 in field treatment of actinic keratosis on face or chest including 12-month follow-up.INGENOL DISOXATE (LEO 43204)LEO PharmaClosed
Dec 14, 2015Efficacy and safety of leo 43204 in field treatment of actinic keratosis on balding scalp including 12-month follow-up.INGENOL DISOXATE (LEO 43204)LEO PharmaClosed
Apr 9, 2015Efficacy and safety of ingenol mebutate gel in field treatment of actinic keratosis on full face, balding scalp or approximately 250 cm2 on the chestPICATO (LP0105, INGENOL MEBUTATE)LEO PharmaOngoing
Dec 17, 2014Ingenol mebutate (picato®) with methyl aminolevulinate photodynamic therapy for the treatment of actinic keratosis.INGENOL MEBUTATEDR. JASON RIVERSClosed
Oct 17, 2014Safety and efficacy of escalating doses of leo 43204 applied once daily for two consecutive days on approximately 250 cm2 on trunk and extremities in subjects…LEO 43204LEO PharmaOngoing
May 22, 2014Leo safety and efficacy of escalating doses of two leo 43204 formulations applied once daily for two consecutive days on full face or approximately 250 cm2 (40…LEO 43204LEO PharmaOngoing

Medicines Authorised in the EU

Newest first
Jul 16, 2021KlisyritirbanibulinAlmirall, S.A.EMA ↗
Aug 23, 2012ZyclaraimiquimodViatris Healthcare LimitedEMA ↗
Dec 13, 2011Ameluz5-aminolevulinic acid hydrochlorideBiofrontera Bioscience GmbHEMA ↗

Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.